Genomed Spólka Akcyjna (WSE:GEN)
Poland · Delayed Price · Currency is PLN 33.00
-0.20 (-0.60%)
At close: Sep 4, 2026
Genomed Spólka Akcyjna Revenue
Genomed Spólka Akcyjna had revenue of 7.13M PLN in the quarter ending June 30, 2026, with 17.47% growth. This brings the company's revenue in the last twelve months to 30.64M, up 21.90% year-over-year. In the year 2025, Genomed Spólka Akcyjna had annual revenue of 29.12M with 26.58% growth.
Revenue (ttm)
30.64M
Revenue Growth
+21.90%
P/S Ratio
1.42
Revenue / Employee
519.39K
Employees
59
Market Cap
43.60M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 29.12M | 6.11M | 26.58% |
| Dec 31, 2024 | 23.01M | 525.20K | 2.34% |
| Dec 31, 2023 | 22.48M | 2.02M | 9.88% |
| Dec 31, 2022 | 20.46M | 565.09K | 2.84% |
| Dec 31, 2021 | 19.89M | 1.14M | 6.08% |
| Dec 31, 2020 | 18.75M | -919.21K | -4.67% |
| Dec 31, 2019 | 19.67M | 1.09M | 5.84% |
| Dec 31, 2018 | 18.59M | 2.23M | 13.61% |
| Dec 31, 2017 | 16.36M | 1.97M | 13.69% |
| Dec 31, 2016 | 14.39M | 4.71M | 48.73% |
| Dec 31, 2015 | 9.68M | 2.35M | 32.05% |
| Dec 31, 2014 | 7.33M | 3.47M | 89.86% |
| Dec 31, 2010 | 3.86M | 2.10M | 118.80% |
| Dec 31, 2009 | 1.76M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| yarrl | 115.77M |
| OPTeam Spólka Akcyjna | 105.73M |
| Remor Solar Polska | 72.20M |
| BioMaxima | 59.74M |
| onesano | 13.27M |
| MedApp | 6.77M |
| Milisystem | 3.44M |
| Lokaty Budowlane | 1.79M |